POLY MEDICURE LTD. - 531768 - Clarification sought from Poly Medicure Ltd
The Exchange has sought clarification from Poly Medicure Ltd on March 2, 2023, with reference to Movement in Volume.The reply is awaited.02-03-2023
02-03-2023
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, in addition to the outcome of Board Meeting given today, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today, have passed a resolution for allotment of 52,500 equity shares of face value of Rs. 5/- each, to the Eligible Employees of the Company, who have exercised their Options. These shares shall rank pari-passu with the existing equity shares of the Company in all respects.28-01-2023
POLY MEDICURE LTD. - 531768 - Quick Financial Results For The Quarter Ended 31St December, 2022
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 28th January, 2023, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses a) Unaudited Financial Results (Consolidate & Standalone) for the Third quarter and nine months ended on 31st December 2022. b) Constituted a Banking Operations Committee of the Company for the purpose of smooth functioning of the business operations of the Company. c) Any Other Item. Please note that the Board Meeting was started at 10.30 AM and concluded at 12:15 PM.28-01-2023
POLY MEDICURE LTD. - 531768 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company
Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 28th January, 2023, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses a) Unaudited Financial Results (Consolidate & Standalone) for the Third quarter and nine months ended on 31st December 2022. b) Constituted a Banking Operations Committee of the Company for the purpose of smooth functioning of the business operations of the Company. c) Any Other Item. Please note that the Board Meeting was started at 10.30 AM and concluded at 12:15 PM.28-01-2023
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Monday, 6th February, 2023 at 4.00 p.m. (IST) for discussing the Un-audited Financial Results of the Company for the quarter ended 31st December, 2022. Link for joining, Dial in and other details of the call are enclosed herewith. ICICI Securities Limited through its representatives along with Company's officials will coordinate the aforesaid meeting.27-01-2023
POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 28Th January, 2023
POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2023 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Saturday, the 28th January, 2023, inter alia to consider the following: a) To consider and approve the Un-Audited Financial Results of the Company for the Third quarter and Nine months ended on 31st December, 2022. b) To transact any other matter which the Board may deem fit.17-01-2023
POLY MEDICURE LTD. - 531768 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dear Sir/Madam, In terms of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we enclose herewith confirmation certificate received from M/s Mas Services Limited, Registrar & Share Transfer Agent of the Company for the quarter ended 31st December, 2022. Request to take the same in your records and oblige.07-01-2023
POLY MEDICURE LTD. - 531768 - Closure of Trading Window
It may please be noted that in compliance with the SEBI (Prohibition to Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider Trading)(Amendment) Regulations 2018 read with clarification given by SSE Circular Ref o.: LIST/COMP/01 /2019-20 dated 02.04.2019 and E letter ref no: NSE/CML/2019/ 11 dated 02.04.2019 read with Company''s Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed for designated person from Sunday, the 1st January, 2023 till the end of 48 hours after the declaration of Financial Results for the quarter ended on 31th December. 2022.31-12-2022
POLY MEDICURE LTD. - 531768 - Regulation 23(9) Related Party Transaction FOR THE HALF YEAR ENDED 30 SEPTEMBER 2022.
Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosures of Related Party Transactions for the half year ended September 30, 2022.16-11-2022
Results Earnings Call for Q2FY23 of Poly Medicure
Conference Call with Poly Medicure Management and Analysts on Q2FY23 Performance and Outlook. Listen to the full earnings transcript.07-11-2022